XOS INC (XOS) Fundamental Analysis & Valuation

NASDAQ:XOS • US98423B3069

Current stock price

1.82 USD
+0.09 (+5.2%)
At close:
1.79 USD
-0.03 (-1.65%)
After Hours:

This XOS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. XOS Profitability Analysis

1.1 Basic Checks

  • XOS had negative earnings in the past year.
  • XOS had a positive operating cash flow in the past year.
  • In the past 5 years XOS reported 4 times negative net income.
  • XOS had negative operating cash flow in 4 of the past 5 years.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • XOS has a Return On Assets of -41.95%. This is amonst the worse of the industry: XOS underperforms 88.55% of its industry peers.
  • XOS has a Return On Equity of -108.73%. This is amonst the worse of the industry: XOS underperforms 86.26% of its industry peers.
Industry RankSector Rank
ROA -41.95%
ROE -108.73%
ROIC N/A
ROA(3y)-57.97%
ROA(5y)-40.46%
ROE(3y)-141.93%
ROE(5y)-95.55%
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300 -400

1.3 Margins

  • XOS's Gross Margin of 5.92% is on the low side compared to the rest of the industry. XOS is outperformed by 89.31% of its industry peers.
  • In the last couple of years the Gross Margin of XOS has declined.
  • XOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.22%
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. XOS Health Analysis

2.1 Basic Checks

  • XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, XOS has more shares outstanding
  • Compared to 5 years ago, XOS has less shares outstanding
  • XOS has a worse debt/assets ratio than last year.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • XOS has an Altman-Z score of -5.51. This is a bad value and indicates that XOS is not financially healthy and even has some risk of bankruptcy.
  • XOS's Altman-Z score of -5.51 is on the low side compared to the rest of the industry. XOS is outperformed by 89.31% of its industry peers.
  • The Debt to FCF ratio of XOS is 3.53, which is a good value as it means it would take XOS, 3.53 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.53, XOS is in the better half of the industry, outperforming 62.60% of the companies in the same industry.
  • XOS has a Debt/Equity ratio of 0.52. This is a neutral value indicating XOS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.52, XOS is in line with its industry, outperforming 45.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 3.53
Altman-Z -5.51
ROIC/WACCN/A
WACC9.41%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

2.3 Liquidity

  • XOS has a Current Ratio of 2.11. This indicates that XOS is financially healthy and has no problem in meeting its short term obligations.
  • XOS has a Current ratio (2.11) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.05 indicates that XOS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.05, XOS is not doing good in the industry: 65.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.05
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. XOS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 37.64% over the past year.
  • Looking at the last year, XOS shows a very negative growth in Revenue. The Revenue has decreased by -17.81% in the last year.
  • The Revenue has been growing by 77.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.86%
Revenue 1Y (TTM)-17.81%
Revenue growth 3Y8.13%
Revenue growth 5Y77.1%
Sales Q2Q%-54.51%

3.2 Future

  • XOS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.11% yearly.
  • Based on estimates for the next years, XOS will show a quite strong growth in Revenue. The Revenue will grow by 11.13% on average per year.
EPS Next Y32.8%
EPS Next 2Y22.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.76%
Revenue Next 2Y17.88%
Revenue Next 3Y13.4%
Revenue Next 5Y11.13%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

2

4. XOS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XOS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XOS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, XOS is valued cheaper than 99.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.84
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • XOS's earnings are expected to grow with 22.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.11%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XOS Dividend Analysis

5.1 Amount

  • No dividends for XOS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XOS Fundamentals: All Metrics, Ratios and Statistics

XOS INC

NASDAQ:XOS (4/8/2026, 5:20:02 PM)

After market: 1.79 -0.03 (-1.65%)

1.82

+0.09 (+5.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-26
Earnings (Next)05-12
Inst Owners3.68%
Inst Owner Change0%
Ins Owners32.88%
Ins Owner Change-1.07%
Market Cap20.62M
Revenue(TTM)45.99M
Net Income(TTM)-25.32M
Analysts76.67
Price Target6.12 (236.26%)
Short Float %5.88%
Short Ratio8.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.79%
Min EPS beat(2)-32.01%
Max EPS beat(2)16.43%
EPS beat(4)2
Avg EPS beat(4)-3.2%
Min EPS beat(4)-32.01%
Max EPS beat(4)16.43%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)6
Avg EPS beat(12)-4.16%
EPS beat(16)9
Avg EPS beat(16)-0.18%
Revenue beat(2)0
Avg Revenue beat(2)-38.35%
Min Revenue beat(2)-70.96%
Max Revenue beat(2)-5.73%
Revenue beat(4)1
Avg Revenue beat(4)-20.12%
Min Revenue beat(4)-70.96%
Max Revenue beat(4)38.96%
Revenue beat(8)1
Avg Revenue beat(8)-21.52%
Revenue beat(12)3
Avg Revenue beat(12)-18.59%
Revenue beat(16)5
Avg Revenue beat(16)-13.77%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-7.03%
EPS NQ rev (3m)-7.03%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF 3.84
P/OCF 3.84
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-3.81
EYN/A
EPS(NY)-2.56
Fwd EYN/A
FCF(TTM)0.47
FCFY26.02%
OCF(TTM)0.47
OCFY26.02%
SpS4.06
BVpS2.06
TBVpS2.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -41.95%
ROE -108.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.92%
FCFM 11.67%
ROA(3y)-57.97%
ROA(5y)-40.46%
ROE(3y)-141.93%
ROE(5y)-95.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.22%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 3.53
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.05
Altman-Z -5.51
F-Score5
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)16.96%
Cap/Depr(5y)279.48%
Cap/Sales(3y)1.22%
Cap/Sales(5y)27.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.86%
EPS Next Y32.8%
EPS Next 2Y22.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.81%
Revenue growth 3Y8.13%
Revenue growth 5Y77.1%
Sales Q2Q%-54.51%
Revenue Next Year25.76%
Revenue Next 2Y17.88%
Revenue Next 3Y13.4%
Revenue Next 5Y11.13%
EBIT growth 1Y27.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.87%
EBIT Next 3Y14.36%
EBIT Next 5Y10.47%
FCF growth 1Y110.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y111%
OCF growth 3YN/A
OCF growth 5YN/A

XOS INC / XOS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for XOS INC?

ChartMill assigns a fundamental rating of 3 / 10 to XOS.


Can you provide the valuation status for XOS INC?

ChartMill assigns a valuation rating of 2 / 10 to XOS INC (XOS). This can be considered as Overvalued.


What is the profitability of XOS stock?

XOS INC (XOS) has a profitability rating of 0 / 10.


Can you provide the financial health for XOS stock?

The financial health rating of XOS INC (XOS) is 4 / 10.